Vectormune FP ILT
Authorised
This medicine is authorised for use in the European Union
Fowlpox and avian infectious laryngotracheitis vaccine (live, recombinant)
MedicineVeterinaryAuthorised
- Application under evaluation
- CVMP opinion
- European Commission decision
Overview
Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website.
Product information
Vectormune FP ILT : EPAR - Product Information
English (EN) (81.49 KB - PDF)
First published: Last updated:
български (BG) (91.78 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
español (ES) (81.51 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
čeština (CS) (92.48 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
dansk (DA) (82.05 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
Deutsch (DE) (81.72 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
eesti keel (ET) (81.22 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
ελληνικά (EL) (91.79 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
français (FR) (81.63 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
hrvatski (HR) (91.56 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
íslenska (IS) (81.52 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
Gaeilge (GA) (81.36 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
italiano (IT) (81.76 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
latviešu valoda (LV) (92.14 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
lietuvių kalba (LT) (92.19 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
magyar (HU) (92.76 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
Malti (MT) (93.86 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
Nederlands (NL) (81.15 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
norsk (NO) (81.52 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
polski (PL) (93.22 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
português (PT) (82.53 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
română (RO) (91.73 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
slovenčina (SK) (81.75 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
slovenščina (SL) (81.76 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
Suomi (FI) (81.11 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
svenska (SV) (81.47 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
Vectormune FP ILT : EPAR - All authorised presentations
English (EN) (81.94 KB - PDF)
First published: Last updated:
български (BG) (93.36 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
español (ES) (81.97 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
čeština (CS) (93.99 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
dansk (DA) (83.34 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
Deutsch (DE) (82.76 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
eesti keel (ET) (82.18 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
ελληνικά (EL) (93.76 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
français (FR) (82.44 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
hrvatski (HR) (92.27 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
íslenska (IS) (83.29 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
Gaeilge (GA) (83.57 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
italiano (IT) (82.29 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
latviešu valoda (LV) (94.29 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
lietuvių kalba (LT) (94.03 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
magyar (HU) (94.15 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
Malti (MT) (95.95 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
Nederlands (NL) (82.05 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
norsk (NO) (82 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
polski (PL) (95.62 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
português (PT) (83.01 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
română (RO) (94.17 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
slovenčina (SK) (94.08 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
slovenščina (SL) (82.27 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
Suomi (FI) (81.54 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
svenska (SV) (82.05 KB - PDF)
First published: 10/09/2021Last updated: 27/05/2024
Product details
- Name of medicine
- Vectormune FP ILT
- Active substance
- recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live
- International non-proprietary name (INN) or common name
- Fowlpox and avian infectious laryngotracheitis vaccine (live, recombinant)
Pharmacotherapeutic group
- Immunologicals for aves
- Live viral vaccines
- Domestic fowl
Authorisation details
- EMA product number
- EMEA/V/C/005482
Assessment history
Vectormune FP ILT : EPAR - Public assessment report
AdoptedReference Number: EMA/565679/2020
English (EN) (81.49 KB - PDF)
First published: Last updated:
CVMP summary of positive opinion for Vectormune FP ILT
AdoptedReference Number: EMA/CVMP/505185/2020
English (EN) (132.19 KB - PDF)
First published:
News on Vectormune FP ILT
This page was last updated on